Ironwood Pharmaceuticals Total Assets:
325.09M for March 31, 2013Ironwood Pharmaceuticals Historical Total Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 325.09M |
| Dec. 31, 2012 | 229.91M |
| Sept. 30, 2012 | 246.52M |
| June 30, 2012 | 208.66M |
| March 31, 2012 | 249.18M |
| Dec. 31, 2011 | 208.98M |
| Sept. 30, 2011 | 219.48M |
| June 30, 2011 | 249.73M |
| March 31, 2011 | 272.02M |
| Dec. 31, 2010 | 301.36M |
| Sept. 30, 2010 | 304.53M |
| June 30, 2010 | 322.08M |
| March 31, 2010 | 338.13M |
| Dec. 31, 2009 | 162.45M |
| Sept. 30, 2009 | 158.85M |
| Dec. 31, 2008 | 138.37M |
About Total Assets
The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More
IRWD Total Assets Benchmarks
| Companies | |
|---|---|
| Forest Laboratories | |
| Synergy Pharmaceuticals | 37.40M |
| Thermo Fisher Scientific | 27.41B |
IRWD Total Assets Rankings
| Overall |
57th percentile 3214 of 7593 |
| Sector |
70th percentile 193 of 650 in Healthcare |
| Industry |
62nd percentile 23 of 61 in Diagnostics & Research |
IRWD Total Assets Range, Past 5 Years
| Minimum | 138.37M | Dec 2008 |
| Maximum | 338.13M | Mar 2010 |
| Average | 245.96M |
IRWD News
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013
Business Wire May 14
Business Wire May 14
